The COVID-19 pandemic will have a significant impact on the US diagnostic imaging market in the short term. Once the market stabilizes, however, the mature diagnostic imaging system market in US will see slow growth through 2029 driven by a growing aging population, increases in health risk factors like poor lifestyle, and adoption of new technology due to favorable regulatory changes. However, overall market expansion will be hindered by a saturated installed base of large imaging systems as well as consolidation of hospitals.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diagnostic imaging systems in the US across a 10-year period.
The COVID-19 pandemic will affect the diagnostic imaging system market.
To what extent will the COVID-19 pandemic impact the US diagnostic imaging system market?
How will the impact of the COVID-19 pandemic differ between segments?
How quickly are procedure volumes expected to rebound?
Purchasing patterns and competitive dynamics in the US will significantly be affected by ongoing hospital consolidation.
How will consolidation impact the purchasing behavior of health systems?
What impact will GPOs have on purchasing patterns?
What will be the competitive implications for larger and smaller OEMs in the US?
The shift toward value-based care is leading to changes in the reimbursement landscape.
How will the ongoing changes to CMS reimbursement rates impact volumes of procedures performed in hospital and nonhospital facilities?
How will diagnostic imaging system manufacturers respond to these changes?
What will be the impact of the shift to value-based care on facilities and manufacturers?
What impact does the ongoing trade war between China and the US have on the diagnostic imaging system market?
How will the trade war impact the performance of Chinese companies in the US market?
How will this affect US manufacturers that rely on Chinese manufacturing materials?
What will be the impact on the overall ASPs of diagnostic imaging devices?
- Diagnostic Imaging Systems - Market Insights - United States
Author(s): Hebri Nandita Mallya
Hebri Nandita Mallya is a research associate within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in Diagnostic Imaging Systems market. Hebri Nandita Mallya holds a Bachelor's degree in Biotechnology, Chemistry and Zoology from Christ University, Bangalore, and a Master's degree in Medical Biochemistry from Manipal Academy of Higher Education.